About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72640 record(s)
Req # A-2024-000339
Adverse Drug Reactions (ADRs). Report numbers: 001047768, 001048898, 001049144, 001066838, 001071905, 001071992, 001072630.Organization: Health Canada
July 2024
Req # A-2024-000341
Adverse Drug Reactions (ADRs). Report numbers: 001074674, 001077121.Organization: Health Canada
July 2024
Req # A-2024-000352
Adverse Drug Reaction (ADR) for Metoclopramide Hydrochloride. Report number: 001078001.Organization: Health Canada
July 2024
Req # A-2024-000373
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-103461-538, National Forum on Artifical Intelligence in Health Care: Accelerating Adoption and Responsible Use in Canada.Organization: Health Canada
July 2024
Req # A-2024-000428
Adverse Drug Reaction (ADR). Report number: 001089392.Organization: Health Canada
July 2024
Req # A-2024-000442
Adverse Drug Reactions (ADRs). Report numbers: 001088375, 001089278, 001089284, 001089287, 001089345, 001090335.Organization: Health Canada
July 2024
July 2024
Req # A-2017-000569
Information provided to the Veterinary Drugs Directorate (VDD) in support of a New Drug Submission for VETOLEXIN 300 MG, VETOLEXIN 75 MG, and VETOLEXIN 750 MG (Drug Identification Numbers (DINs) 02463369, 02463350, 02463385 respectively).…Organization: Health Canada
July 2024
Req # A-2020-000580
All documents related to enforcement regarding, or seizures of, STLTH or Sorbae vaping products under the Tobacco and Vaping Products Act.Organization: Health Canada
July 2024
Req # A-2020-001404
Provide the earliest or early versions of Guide 116 and Guide 117 as well as the most recent versions of the same documents that have been prepared for approval, along with any associated emails related to their development, records of decisions and…Organization: Health Canada
July 2024